Newsroom
Psomagen Adds LevitasBio’s Technology for Single-Cell Applications
August 27, 2024
Psomagen has announced the expansion of its single-cell capabilities by integrating the LevitasBio LeviCell EOS system into its service. This cutting-edge technology is a solution of choice to enhance the gentle purification process before single-cell sequencing, supporting clients’ needs for consistent, high-quality data. Alongside this, Psomagen has also incorporated Parse Biosciences into its single-cell portfolio, further strengthening its commitment to advanced cellular research.
Psomagen added the LeviCell EOS to give its clients a gentle purification step before single-cell sequencing. The step is especially useful for removing dead cells after cryopreservation.